I alle fire undersøgelser blev dosen af Lacosamid Pain UCB Pharma gradvist forøget over nogle få uger og var herefter fast i 12 uger.
In all four studies, the dose of Lacosamide Pain UCB Pharma was increased gradually over a few weeks before being maintained at a stable dose for 12 weeks.